Effectiveness of CAM Therapy: Understanding the Evidence (Q37827224)

23 August 2017

1 reference

title

Effectiveness of CAM therapy: understanding the evidence (English)

1 reference

23 August 2017

Effectiveness of CAM Therapy: Understanding the Evidence (English)

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

21 November 2024

1

Roland Staud

1 reference

23 August 2017

language of work or name

1 reference

3 December 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0889857X1000102X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

https://api.elsevier.com/content/article/PII:S0889857X1000102X?httpAccept=text/plain

21 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Rheumatic Diseases Clinics of North America

21 November 2024

published in

1 reference

23 August 2017

volume

37

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

9-17

1 reference

Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia

23 August 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

A meta-analysis of fibromyalgia treatment interventions

21 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Acupuncture for fibromyalgia--a systematic review of randomized clinical trials

21 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Complementary treatments in rheumatic diseases

21 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

A systematic review of homoeopathy for the treatment of fibromyalgia

21 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Complementary and alternative therapies for fibromyalgia

21 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Methodology and Reports of Systematic Reviews and Meta-analyses

21 November 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Going from evidence to recommendations

21 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Circular instead of hierarchical: methodological principles for the evaluation of complex interventions

21 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Evidence summaries and synthesis: necessary but insufficient approach for determining clinical practice of integrated medicine?

21 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Proposal for an integrated evaluation model for the study of whole systems health care in cancer

21 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap

21 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

21 November 2024

The powerful placebo

20

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Role of pain in placebo analgesia

21 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia

21 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Placebo and opioid analgesia-- imaging a shared neuronal network

21 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Response variability to analgesics: a role for non-specific activation of endogenous opioids.

21 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Potentiation of placebo analgesia by proglumide

21 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Placebo and naloxone can alter post-surgical pain by separate mechanisms

21 November 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Influence of the method of drug administration on analgesic response

21 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms

21 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients

21 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Repeatability of autonomic responses to pain anticipation and pain stimulation

21 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Powerful placebo: the dark side of the randomised controlled trial.

21 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

What are the main methodological problems in the estimation of placebo effects?

21 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

The power of context: reconceptualizing the placebo effect

21 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Deconstructing the placebo effect and finding the meaning response

21 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

21 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

21 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Meta-analysis: The treatment of irritable bowel syndrome

21 November 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 November 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Importance of Measuring Placebo Factors in Complex Clinical Trials

21 November 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Role of Placebo Factors in Clinical Trials with Special Focus on Enrichment Designs

21 November 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Publication bias in meta-analysis: its causes and consequences

21 November 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

21 November 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

How much of the placebo ‘effect’ is really statistical regression?

21 November 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Assessing efficacy of complementary medicine: adding qualitative research methods to the "Gold Standard".

21 November 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Whole systems research: a discipline for studying complementary and alternative medicine

21 November 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

The placebo-controlled trial as a test of complementary and alternative medicine: observations from research experience of individualised homeopathic treatment

21 November 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis.

21 November 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

United Kingdom back pain exercise and manipulation (UK BEAM) randomised trial: cost effectiveness of physical treatments for back pain in primary care

21 November 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Impact of participant and physician intervention preferences on randomized trials: a systematic review

21 November 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Patient preferences in randomised controlled trials: conceptual framework and implications for research

21 November 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

Asian-American physicians distinguish between licensed acupuncturists and physicians who incorporate acupuncture into their practices

21 November 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.11.009

21 November 2024

Identifiers

1 reference

23 August 2017

1 reference